Lupin launches HIV drug in the US with marketing exclusivity

Drug major Lupin Wednesday said it has launched the generic version of ViiV Healthcare`s (ViiV) Trizivir tablets in the US market with 180-days of marketing exclusivity.

Lupin gets USFDA nod for heart disease drug

Drug major Lupin Thursday said it has received US health regulator`s approval to market generic version of Gilead Sciences, Inc`s Ranexa tablets, a drug used to treat heart disease, in the American market.

Lupin gets USFDA nod for Armodafinil and Doxycycline

Drug firm Lupin today said the company`s US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsules from the US health regulator.

Lupin gets USFDA nod for generic hypertension drug

Drug major Lupin on Friday said it has received US health regulator`s approval to market generic version of Novartis Pharmaceuticals Corp`s Diovan HCT Tablets, a hypertension drug, in the American market.

Lupin receives USFDA nod for Lorazepam Oral Concentrate

Drug firm Lupin today said it has received US health regulator`s approval to market its generic Lorazepam Oral Concentrate, used for treating anxiety disorders, in the American market.

Lupin gets USFDA nod for generic oral contraceptive

The product is generic equivalent of Teva Branded Pharmaceutical Products R&D Inc`s Plan B Tablets and is indicated for prevention of pregnancy following unprotected intercourse.

Lupin launches generic cholesterol lowering drug in US

Drug-maker Lupin Tuesday said its subsidiary Lupin Pharmaceuticals Inc has launched cholesterol lowering drug Fenofibrate tablets in 48mg and 145mg strengths in the United States.

Lupin gets USFDA approval for generic Lexapro tablets

Drug firm Lupin Ltd today said it has received American health regulator`s approval to market Escitalopram tablets, used in treating depressive disorders, in the US market.

USFDA approval for Lupin`s generic oral contraceptive

Pharma firm Lupin Ltd said it has received USFDA`s approval to sell generic version of oral contraceptive, Ortho Tri-cyclen Lo tablets.

Lupin, Aurobindo get USFDA nod for HIV drug

Drug firms Lupin Ltd and Aurobindo Pharma today said they have received US health regulator`s approval to sell generic Combivir tablets, used in treating HIV infection, in the American market.

Lupin resumes anti-diabetic drug sales in US

Drug firm Lupin today said it has resumed sales of generic version of Shionogi`s Fortamet tablets.

Lupin settles patent dispute with US firms

Drug maker Lupin today said it has reached a patent litigation settlement agreement with US-based firms Santarus Inc and Depomed Inc.

Lupin eyes $200 mn opportunity in US contraceptives market

Mumbai-based pharmaceutical firm Lupin is gearing to tap opportunities to the tune of up to USD 200 million in the US oral contraceptives market, despite patent litigation from rivals on its plans to sell generic drugs there.

Lupin buys anti-cholesterol drug rights for USD 39 mn

Indian pharmaceuticals major Lupin on Tuesday said it had acquired the rights for Antara, a drug to treat high blood cholesterol and high triglycerides, for USD 38.61 million from the US-based Oscient Pharmaceuticals.

Lupin`s three subsidiaries to merge with itself

Drug maker Lupin today said its three of its 100 per cent subsidiaries, including Lupin Pharmacare, would merge with the parent company.

Lupin to borrow up to Rs 500 cr; appoints Deloitte as auditor

Pharma firm Lupin today said it will borrow up to Rs 500 crore from corporate bodies and various financial institutions.